Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity - Narrative (Details)

v3.22.1
Stockholders’ Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Feb. 23, 2021
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Jun. 03, 2021
Subsidiary, Sale of Stock [Line Items]          
Public offering (in shares) 2,127,660        
Proceeds from public offering of common stock, net of offering costs $ 46,800 $ 0   $ 46,785  
Unrecognized compensation expense   $ 900      
Weighted average period (in years)   1 year 9 months 18 days      
Purchase plan, shares purchased (in shares)     22,918    
Warrants, terms (in years)   5 years      
Restricted Stock          
Subsidiary, Sale of Stock [Line Items]          
Unrecognized compensation expense   $ 2,700      
Weighted average period (in years)   2 years 1 month 6 days      
Employee Stock Purchase Plan          
Subsidiary, Sale of Stock [Line Items]          
Grant (in shares)   377,082     400,000
Purchase plan, per share weighted average price of shares purchased (in dollars per share)     $ 9.78    
IPO          
Subsidiary, Sale of Stock [Line Items]          
Public offering (in shares) 2,127,660        
Common stock initially offered at public offering (in shares) 1,850,140        
Sale of stock, price per share (in dollars per share) $ 23.50        
Shares sold pursuant to exercise of underwriters option (in shares) 277,520        
Price per share for underwriters option to purchase (in dollars per share) $ 22.09        
Proceeds from public offering of common stock, net of offering costs $ 46,800